GF

VUB researchers show xCT protein is key link in inhibiting pancreatic cancer growth and limiting mood disturbances

VUB researchers design medicine of the future

Newly discovered protein blocks sleeping sickness

VUB research team discovers essential protein that contributes to liver fibrosis

VUB professor discovers genetic cause of low birth weight among children conceived after fertility treatment

VUB researcher aims to ease discomfort around end-of-life suffering

VUB to lead international consortium on palliative care for chronic lung disease

VUB team develops breakthrough nanobody technology against liver inflammation 

Mathieu Vinken, a professor in the In Vitro Toxicology and Dermato-cosmetology (IVTD) lab at the Vrije Universiteit Brussel, and doctoral student Raf Van Campenhout have developed a technique based on nanobody technology to prevent liver inflammation. Nanobodies, or single-domain antibodies, are fragments of antibodies that can selectively bind to a specific antigen. Because they are simple to produce and react in very specific ways, they are often used in various biotechnological, therapeutic and diagnostic applications.  

VUB researcher develops 3D model of the testis 

VUB maps complexity of pancreatic tumours 

VUB µFlow Cell partner of Redwire Space NV to develop 3D BioSystem for European Space Agency

Four awards for VUB in annual KVAB prize for science communication